Shankar Thangamani

2.2k total citations
48 papers, 1.7k citations indexed

About

Shankar Thangamani is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Shankar Thangamani has authored 48 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 19 papers in Epidemiology and 16 papers in Molecular Biology. Recurrent topics in Shankar Thangamani's work include Antifungal resistance and susceptibility (27 papers), Fungal Infections and Studies (16 papers) and Gut microbiota and health (8 papers). Shankar Thangamani is often cited by papers focused on Antifungal resistance and susceptibility (27 papers), Fungal Infections and Studies (16 papers) and Gut microbiota and health (8 papers). Shankar Thangamani collaborates with scholars based in United States, Saudi Arabia and India. Shankar Thangamani's co-authors include Mohamed N. Seleem, Waleed Younis, Haroon Mohammad, Mostafa F. N. Abushahba, Tiago J. P. Sobreira, Tony R. Hazbun, Lake N. Paul, Victoria Hedrick, Larisa Avramova and Shaohua Wang and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Shankar Thangamani

48 papers receiving 1.7k citations

Peers

Countries citing papers authored by Shankar Thangamani

Since Specialization

Citations

This map shows the geographic impact of Shankar Thangamani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shankar Thangamani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shankar Thangamani more than expected).

Fields of papers citing papers by Shankar Thangamani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shankar Thangamani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shankar Thangamani. The network helps show where Shankar Thangamani may publish in the future.

Co-authorship network of co-authors of Shankar Thangamani

This figure shows the co-authorship network connecting the top 25 collaborators of Shankar Thangamani. A scholar is included among the top collaborators of Shankar Thangamani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shankar Thangamani. Shankar Thangamani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single-cell transcriptomics unveils skin cell specific antifungal immune responses and IL-1Ra- IL-1R immune evasion strategies of emerging fungal pathogen Candida auris 2024 ·PLoS Pathogens ·(unknown), (unknown), Abhishek Datta, Abtar Mishra, (unknown), (unknown), M. G. Netea, Vinod Kumar, Michail S. Lionakis, Devender Arora, Jyothi Thimmapuram, Shankar Thangamani	8
2	Cell aggregation mediated by ACE2 deletion in Candida auris modulates fungal colonization and host immune responses in the skin 2024 ·mSphere ·(unknown), Abigail Cox, Shankar Thangamani	5
3	Intestinal colonization with Candida auris and mucosal immune response in mice treated with cefoperazone oral antibiotic 2023 ·Frontiers in Immunology ·(unknown), Harm HogenEsch, Shankar Thangamani	10
4	Tools and techniques to identify, study, and control Candida auris 2023 ·PLoS Pathogens ·(unknown), Anuradha Chowdhary, Douglas A. Bernstein, Shankar Thangamani	8
5	An Ex vivo Assay to Study <em>Candida albicans</em> Hyphal Morphogenesis in the Gastrointestinal Tract 2020 ·Journal of Visualized Experiments ·(unknown), (unknown), Shankar Thangamani	1
6	Discovery of diazahexa/hepta cyclic cage-like compounds with broad-spectrum antifungal activity against Candida and Cryptococcus species 2019 ·RSC Advances ·(unknown), Natarajan Arumugam, Abdulrahman I. Almansour, Raju Suresh Kumar, Shankar Thangamani	2
7	Antibiotic-induced decreases in the levels of microbial-derived short-chain fatty acids correlate with increased gastrointestinal colonization of Candida albicans 2019 ·Scientific Reports ·(unknown), Shaohua Wang, Tony R. Hazbun, Hariom Yadav, Shankar Thangamani	110
8	Broad-spectrum antifungal activity of spirooxindolo-pyrrolidine tethered indole/imidazole hybrid heterocycles against fungal pathogens 2019 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Natarajan Arumugam, Abdulrahman I. Almansour, Raju Suresh Kumar, Keiji Maruoka, Vijay C. Antharam, Shankar Thangamani	40
9	Multicomponent Domino Synthesis, Anticancer Activity and Molecular Modeling Simulation of Complex Dispirooxindolopyrrolidines 2018 ·Molecules ·Natarajan Arumugam, Abdulrahman I. Almansour, Raju Suresh Kumar, Govindasami Periyasami, (unknown), (unknown), Vaiyapuri Subbarayan Periasamy, Ali A. Alshatwi, Sakkarapalayam M. Mahalingam, Shankar Thangamani, J. Carlos Menéndez	11
10	Repurposing Approach Identifies Auranofin with Broad Spectrum Antifungal Activity That Targets Mia40-Erv1 Pathway 2017 ·Frontiers in Cellular and Infection Microbiology ·Shankar Thangamani, Matthew C. Maland, Haroon Mohammad, Pete E. Pascuzzi, Larisa Avramova, Carla M. Koehler, Tony R. Hazbun, Mohamed N. Seleem	75
11	Impact of different cell penetrating peptides on the efficacy of antisense therapeutics for targeting intracellular pathogens 2016 ·Scientific Reports ·Mostafa F. N. Abushahba, Haroon Mohammad, Shankar Thangamani, (unknown), Mohamed N. Seleem	73
12	Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells 2016 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Shankar Thangamani, Hassan E. Eldesouky, Haroon Mohammad, Pete E. Pascuzzi, Larisa Avramova, Tony R. Hazbun, Mohamed N. Seleem	91
13	Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens 2016 ·Scientific Reports ·Shankar Thangamani, Haroon Mohammad, Mostafa F. N. Abushahba, Tiago J. P. Sobreira, Victoria Hedrick, Lake N. Paul, Mohamed N. Seleem	166
14	Repurposing celecoxib as a topical antimicrobial agent 2015 ·Frontiers in Microbiology ·Shankar Thangamani, Waleed Younis, Mohamed N. Seleem	73
15	Antimicrobial Peptides and Peptidomimetics - Potent Therapeutic Allies for Staphylococcal Infections 2015 ·Current Pharmaceutical Design ·Haroon Mohammad, Shankar Thangamani, Mohamed N. Seleem	55
16	Antibacterial activity and therapeutic efficacy of Fl-PRPRPL-5, a cationic amphiphilic polyproline helix, in a mouse model of staphylococcal skin infection 2015 ·Drug Design Development and Therapy ·Mohamed N. Seleem, Shankar Thangamani, (unknown), Jean Chmielewski	14
17	Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent 2015 ·Scientific Reports ·Shankar Thangamani, Haroon Mohammad, Mostafa F. N. Abushahba, Maha I. Hamed, Tiago J. P. Sobreira, Victoria Hedrick, Lake N. Paul, Mohamed N. Seleem	110
18	Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections 2015 ·Current Pharmaceutical Design ·Waleed Younis, Shankar Thangamani, Mohamed N. Seleem	81
19	Drug Repurposing for the Treatment of Staphylococcal Infections 2015 ·Current Pharmaceutical Design ·Shankar Thangamani, Haroon Mohammad, Waleed Younis, Mohamed N. Seleem	46
20	Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens 2015 ·PLoS ONE ·Shankar Thangamani, Waleed Younis, Mohamed N. Seleem	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact